Common variants in glyoxalase I do not increase chronic pancreatitis risk

Kaune, Tom; Hollenbach, Marcus*; Keil, Bettina; Chen, Jian-Min; Masson, Emmanuelle; Becker, Carla; Damm, Marko; Ruffert, Claudia; Grützmann, Robert; Hoffmeister, Albrecht; Te Morsche, Rene H M; Cavestro, Giulia Martina; Zuppardo, Raffaella Alessia; Saftoiu, Adrian; Malecka-Panas, Ewa; Głuszek, Stanislaw; Bugert, Peter; Lerch, Markus M; Weiss, Frank Ulrich; Zou, Wen-Bin; Liao, Zhuan; Hegyi, Peter [Hegyi, Péter (Gasztroenterológia), szerző] I.sz. Belgyógyászati Klinika (PTE / ÁOK); MTA-SZTE Lendület Gasztroenterológiai Multidisz... (SZTE / ÁOK / I.BelK); Transzlációs Medicina Intézet (PTE / ÁOK); Drenth, Joost Ph; Riedel, Jan; Férec, Claude; Scholz, Markus; Kirsten, Holger; Tóth, Andrea; Ewers, Maren; Witt, Heiko; Griesmann, Heidi; Michl, Patrick; Rosendahl, Jonas

Angol nyelvű Tudományos Sokszerzős vagy csoportos szerzőségű szakcikk (Folyóiratcikk)
Megjelent: PLOS ONE 1932-6203 1932-6203 14 (10) Paper: e0222927 , 14 p. 2019
  • Pedagógiai Tudományos Bizottság: A
  • Szociológiai Tudományos Bizottság: A
  • SJR Scopus - Agricultural and Biological Sciences (miscellaneous): Q1
Azonosítók
Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in increased ROS. Single nucleotide polymorphisms (SNPs) of GLO1 have been linked to various inflammatory diseases. Here, we analyzed whether common GLO1 variants are associated with alcoholic (ACP) and non-alcoholic CP (NACP).Using melting curve analysis, we genotyped a screening cohort of 223 ACP, 218 NACP patients, and 328 controls for 11 tagging SNPs defined by the SNPinfo LD TAG SNP Selection tool and the functionally relevant variant rs4746. For selected variants the cohorts were extended to up to 1,441 patient samples.In the ACP cohort, comparison of genotypes for rs1937780 between patients and controls displayed an ambiguous result in the screening cohort (p = 0.08). However, in the extended cohort of 1,441 patients no statistically significant association was found for the comparison of genotypes (p = 0.11), nor in logistic regression analysis (p = 0.214, OR 1.072, 95% CI 0.961-1.196). In the NACP screening cohort SNPs rs937662, rs1699012, and rs4746 displayed an ambiguous result when patients were compared to controls in the recessive or dominant model (p = 0.08, 0.08, and 0.07, respectively). Again, these associations were not confirmed in the extended cohorts (rs937662, dominant model: p = 0.07, logistic regression: p = 0.07, OR 1.207, 95% CI 0.985-1.480) or in the replication cohorts for rs4746 (Germany, p = 0.42, OR 1.080, 95% CI 0.673-1.124; France, p = 0.19, OR 0.90, 95% CI 0.76-1.06; China, p = 0.24, OR 1.18, 95% CI 0.90-1.54) and rs1699012 (Germany, Munich; p = 0.279, OR 0.903, 95% CI 0.750-1.087).Common GLO1 variants do not increase chronic pancreatitis risk.
Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSL
2020-02-17 11:38